Drug Shortage Report for AURO-LACOSAMIDE

Last updated on 2020-12-04 History
Report ID 107501
Drug Identification Number 02475332
Brand name AURO-LACOSAMIDE
Common or Proper name Lacosamide
Company Name AURO PHARMA INC
Market Status MARKETED
Active Ingredient(s) LACOSAMIDE
Strength(s) 50MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 60
ATC code N03AX
ATC description ANTIEPILEPTICS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2020-02-26
Estimated end date 2020-11-30
Actual end date 2020-12-03
Shortage status Resolved
Updated date 2020-12-04
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 3700 STEELES AVENUE WEST, SUITE 402
WOODBRIDGE, ONTARIO
CANADA L4L 8K8
Company contact information Balaji Srinivasan

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v18 2020-12-04 French Compare
v17 2020-12-04 English Compare
v16 2020-10-14 French Compare
v15 2020-10-14 English Compare
v14 2020-09-29 French Compare
v13 2020-09-29 English Compare
v12 2020-08-14 French Compare
v11 2020-08-14 English Compare
v10 2020-07-30 French Compare
v9 2020-07-30 English Compare
v8 2020-06-19 French Compare
v7 2020-06-19 English Compare
v6 2020-05-22 French Compare
v5 2020-05-22 English Compare
v4 2020-04-08 French Compare
v3 2020-04-08 English Compare
v2 2020-02-28 French Compare
v1 2020-02-28 English Compare

Showing 1 to 18 of 18